From my conversations $35 AUD will not get a look in for board approval so would have to be hostile. $35 US might get over the line. IMO these values will be reached organically anyway if PMS phase 3 trial is positive in 2 years or so which as I've said before I believe is highly likely.
IMO the buyback is simply in response to the recent windfall and is a reasonable use of excess capital although like most medium - large holders I personally would have preferred a dividend. JP is clearly as frustrated as any of us at the price action over the last 6-10 months despite the positive milestones NEU has met as highlighted by hottod et al recently.
I am convinced JP and co know exactly what they have under the bonnet and it isn't $35 AUD/share. AIMO.
- Forums
- ASX - By Stock
- NEU
- Ann: Update - Notification of buy-back - NEU
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.58%
!
$13.24

Ann: Update - Notification of buy-back - NEU, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.24 |
Change
0.700(5.58%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.96 | $13.35 | $12.91 | $1.790M | 135.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2222 | $13.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.24 | 178 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.270 |
1 | 150 | 13.260 |
5 | 680 | 13.250 |
6 | 7776 | 13.240 |
3 | 411 | 13.230 |
Price($) | Vol. | No. |
---|---|---|
13.310 | 1530 | 3 |
13.320 | 436 | 3 |
13.330 | 2176 | 5 |
13.340 | 592 | 3 |
13.350 | 1092 | 3 |
Last trade - 10.10am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online